Unknown PHASE1 INTERVENTIONAL 1-arm NCT01335568

Hepatocyte Matrix Implant Study Indonesia (HMIIndo)

Intracorporeal Autologous Hepatocyte Matrix Implant: A New Tissue Engineering Procedure for Treatment of Hepatic Disease

Sponsor: Baermed

Conditions Chronic Liver Disease Liver Cirrhosis Liver Insufficiency

Interventions Hepatocyte Matrix Implant

Updated 5 times since 2017 Last updated: Apr 13, 2011 Started: Apr 30, 2011 Primary completion: Dec 31, 2011 Completion: Dec 31, 2012

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Chronic Liver Disease and Liver Cirrhosis, this trial is ongoing. The trial is conducted by Baermed and has accumulated 5 data snapshots since 2011. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE1
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE1

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE1
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE1
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE1

First recorded

Apr 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Baermed

Data source: Baermed

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Jakarta, Indonesia